Wave Life Sciences   Report issue

For profit Phase 2 Phase 3
Founded: Boston MA United States (2012)

Organization Overview

First Clinical Trial
2017
NCT03225833
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Wave Life Sciences | WAVE Life Sciences | Wave Life Sciences Ltd.